Yeshwant Krishna is a corporate insider at Verve Therapeutics, Inc. (VERV) filing SEC Form 4 transactions. 60 transactions across 3 companies, totaling $18,000,000 in purchases and $43,791,308 in sales. Source: SEC EDGAR.
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. VERV | Disposition | 42,200 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 136,139 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | U | 1,800,000 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | U | 4,260,047 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | U | 6,108,442 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 42,200 | - | - | 42,200 | 6/5/2025 Filed: 6/6/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 136,139 | - | - | 136,139 | 6/26/2024 Filed: 6/28/2024 | Filing → |
Verve Therapeutics, Inc. VERV | Purchase | 1,800,000 | $10.00 | $18.00M | 1,800,000 | 12/1/2023 Filed: 12/5/2023 | Filing → |
EQRx, Inc. EQRX | Disposition | 101,010 | $0.00 | $0 | 0 | 11/9/2023 Filed: 11/9/2023 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 26,642 | $0.00 | $0 | 26,642 | 6/15/2023 Filed: 6/20/2023 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 243 | $32.90 | $8K | 4,260,047 | 11/4/2022 Filed: 11/8/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 650 | $31.99 | $21K | 4,260,290 | 11/4/2022 Filed: 11/8/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 47,690 | $31.12 | $1.48M | 4,260,940 | 11/4/2022 Filed: 11/8/2022 | Filing → |
Verve Therapeutics, Inc. VERV | J | 48,583 | $0.00 | $0 | 6,108,442 | 11/4/2022 Filed: 11/8/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 1,755 | $33.84 | $59K | 4,308,630 | 11/3/2022 Filed: 11/4/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 25,534 | $33.14 | $846K | 4,310,385 | 11/3/2022 Filed: 11/4/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 22,279 | $32.32 | $720K | 4,335,919 | 11/3/2022 Filed: 11/4/2022 | Filing → |
Verve Therapeutics, Inc. VERV | J | 49,569 | $0.00 | $0 | 6,157,025 | 11/3/2022 Filed: 11/4/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 8,930 | $36.77 | $328K | 4,358,198 | 11/2/2022 Filed: 11/4/2022 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 10,372 | $36.28 | $376K | 4,367,128 | 11/2/2022 Filed: 11/4/2022 | Filing → |
Try asking...